Inequities in healthcare are pervasive, but individual rheumatologists can actively participate in efforts to improve outcomes by changing the ways in which they interact with patients. Dubois Lecturer Candace H. Feldman, MD, MPH, ScD, will explain how.

Raphaela Goldbach-Mansky, MD, MHS, will illustrate how pediatric discoveries have helped to link innate immune pathway dysregulation to systemic inflammation and progressive organ damage.

Nunzio Bottini, MD, PhD, will outline the established role of synovial fibroblasts, as well as recent discoveries, making the case that targeting them would solve unmet needs in rheumatoid arthritis.

Mary Beth Humphrey, MD, PhD, will trace the chronology of key advances and current questions driving this interdisciplinary field that explores the roles of shared molecules and interactions between the immune system and the skeleton.

“Dr. Flood demonstrated, in so many different ways, the impact that one individual can have on our specialty, and he serves as a tremendous example of how we should all aspire to participate, even in small ways, to continue to develop and foster the sense…

ACR President Deborah Dyett Desir, MD, reflects on the ever-evolving research and practices in rheumatology and outlines her priorities for the ACR membership, including the promotion of advocacy, global outreach, innovation, and diversity, equity, and inclusion.

Speakers are asked to “Show Me Your Best Cases” in adult and pediatric rheumatology. Top-ranking presentations are also featured in poster sessions over three days.

Karen B. Onel, MD, and Randy Cron, MD, PhD, will debate whether using biologics that revolutionized the care of many children with systemic juvenile idiopathic arthritis is the right thing to do given safety concerns.